ToxSci Advance Access published online on January 8, 2009
Toxicological Sciences, doi:10.1093/toxsci/kfp002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Valproic Acid-induced Deregulation In Vitro of Genes Associated In Vivo With Neural Tube Defects
* Department of Pharmaceutical Biosciences, Division of Toxicology, Uppsala University, BMC, Box 594, SE-75124 Uppsala, Sweden
Safety Assessement, AstraZeneca R&D Södertälje, SE-15185 Södertälje, Sweden
2 Corresponding author: Michael Stigson, Ph.D., Department of Pharmaceutical Biosciences, Division of Toxicology, Uppsala University, BMC, Box 594, SE-75124 Uppsala, Sweden, Telephone: +46-18-4714993, Fax: +46-18-4714253, E-mail: michael.stigson{at}farmbio.uu.se
Received September 28, 2008; revision received December 26, 2008; accepted January 5, 2009
 |
Abstract |
|---|
The utility of an in vitro system to search for molecular targets and markers of developmental toxicity was explored, using microarrays to detect genes susceptible to deregulation by the teratogen valproic acid (VPA) in the pluripotent mouse embryonal carcinoma cell line P19. Total RNA extracted from P19 cells cultured in the absence or presence of 1mM, 2.5mM or 10mM VPA for 1.5h, 6h or 24h was subjected to replicated microarray analysis, using CodeLinkTM UniSet I Mouse 20K Expression Bioarrays. A moderated F test revealed a significant VPA response for 2,972 (p < 10-3) array probes (19.4% of the filtered gene list), 421 of which were significant across all time points. In a core subset of VPA target genes whose expression was down-regulated (68 genes) or up-regulated (125 genes) with high probability (p < 10-7) after both 1.5h and 6h of VPA exposure, there was a significant enrichment of the biological process Gene Ontology term transcriptional regulation among down-regulated genes, and apoptosis among up-regulated, and two of the down-regulated genes (Folr1 and Gtf2i) have a knockout phenotype comprising exencephaly, the major malformation induced by VPA in mice. The VPA-induced gene expression response in P19 cells indicated that 
30% of the 200 genes known from genetic mouse models to be associated with neural tube defects may be potential VPA targets, suggestive of a combined deregulation of multiple genes as a possible mechanism of VPA teratogenicity. Gene expression responses related to other known effects of VPA (histone deacetylase inhibition, G1-phase cell cycle arrest, induction of apoptosis) were also identified. This study indicates that toxicogenomic responses to a teratogenic compound in vitro may correlate with known in vitro and in vivo effects, and that short-time (
6 h) exposures in such an in vitro system could provide a useful component in mechanistic studies and screening tests in developmental toxicology.
Key Words: alternative methods; embryonal carcinoma cells; exencephaly; histone deacetylase inhibitor; in vitro toxicology; microarray; neural tube defects; teratogen; toxicogenomics; valproic acid.
1 Current address: Department of Medical Sciences, Division of Clinical Pharmacology, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, and Department of Physical and Analytical Chemistry, Division of Analytical Chemistry, Uppsala University, BMC, Box 599, SE-751 24 Uppsala, Sweden